Latest News

Filters

Filter by tags: Netherlands CANDU reactor Clear all tag filters

3 news articles found

The Roadmaps to New Nuclear conference, organised by the French Ministry for Energy Transition and the OECD’s Nuclear Energy Agency (NEA) in Paris, resulted in two communiques signed by energy ministers and industry representatives emphasising the need for nuclear energy.

Source: NEI Magazine
Date: Tuesday, 03 October 2023
Original article: neimagazine.com/news/newsfrance-and-nea-host-conference-to-promote-nuclear-energy-11186484

Representatives of the nuclear industry in OECD nations, and representatives of the governments of 20 countries, have issued communiqués committing to work together to expand nuclear energy capacity, after the inaugural Roadmaps to New Nuclear conference organised by the OECD Nuclear Energy Agency (NEA) and the French government.

Source: World Nuclear News
Date: Saturday, 30 September 2023
Original article: world-nuclear-news.org/Articles/Nuclear-groups-and-ministers-pledge-to-back-new-nu

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Source: Nucnet
Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023